申请人:Ajinomoto Co., Inc.
公开号:EP3162366A1
公开(公告)日:2017-05-03
The present invention aims to provide a sweetness receptor antagonist useful for the prophylaxis or treatment of metabolic syndrome, diabetes, obesity and the like. A sweetness receptor antagonist containing a compound represented by the formula (I)
wherein each symbol is as described in the DESCRIPTION, or a salt thereof.
本发明旨在提供一种甜味受体拮抗剂,用于预防或治疗代谢综合征、糖尿病、肥胖症等。甜味受体拮抗剂含有由式(I)代表的化合物
其中各符号如说明书所述,或其盐。